Index RUT P/E - EPS (ttm) -0.90 Insider Own 3.41% Shs Outstand 191.38M Perf Week -0.76%
Market Cap 239.30M Forward P/E - EPS next Y -0.65 Insider Trans -2.08% Shs Float 177.81M Perf Month 2.36%
Income -177.08M PEG - EPS next Q -0.20 Inst Own 71.63% Short Float 4.63% Perf Quarter 12.07%
Sales 93.16M P/S 2.57 EPS this Y 45.98% Inst Trans -4.27% Short Ratio 5.43 Perf Half Y 44.88%
Book/sh 0.43 P/B 3.00 EPS next Y 17.66% ROA -42.28% Short Interest 8.24M Perf Year 83.10%
Cash/sh 1.47 P/C 0.88 EPS next 5Y -7.30% ROE -128.02% 52W Range 0.41 - 1.93 Perf YTD 130.09%
Dividend Est. - P/FCF - EPS past 5Y - ROI -63.71% 52W High -32.57% Beta 0.60
Dividend TTM - Quick Ratio 4.90 Sales past 5Y -20.42% Gross Margin 59.22% 52W Low 215.08% ATR (14) 0.09
Dividend Ex-Date - Current Ratio 5.15 EPS Y/Y TTM 44.63% Oper. Margin -145.03% RSI (14) 54.39 Volatility 6.54% 7.47%
Employees 137 Debt/Eq 2.76 Sales Y/Y TTM 6.17% Profit Margin -190.09% Recom 3.40 Target Price 1.65
Option/Short Yes / Yes LT Debt/Eq 2.49 EPS Q/Q 7.01% Payout - Rel Volume 1.58 Prev Close 1.27
Sales Surprise 12.90% EPS Surprise -35.14% Sales Q/Q 14.59% Earnings Aug 08 AMC Avg Volume 1.52M Price 1.30
SMA20 3.85% SMA50 1.41% SMA200 21.76% Trades
Volume 2,400,555 Change 2.36%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-28-24 Initiated Rodman & Renshaw
Buy
$2
Nov-20-23 Resumed JP Morgan
Underweight
Nov-09-23 Upgrade TD Cowen
Market Perform → Outperform
May-10-23 Upgrade Jefferies
Underperform → Hold
$1.50 → $1
Feb-24-23 Downgrade Jefferies
Hold → Underperform
$3.20 → $1.50
Aug-08-22 Downgrade JP Morgan
Neutral → Underweight
May-31-22 Resumed Jefferies
Hold
$12 → $4
Apr-18-22 Downgrade Goldman
Neutral → Sell
$3
Mar-15-22 Downgrade Mizuho
Buy → Neutral
$35 → $8
Mar-15-22 Downgrade Cowen
Outperform → Market Perform
Mar-14-22 Downgrade William Blair
Outperform → Mkt Perform
Mar-14-22 Downgrade Stifel
Buy → Hold
$24 → $5
Mar-14-22 Downgrade BTIG Research
Buy → Neutral
Mar-14-22 Downgrade BofA Securities
Neutral → Underperform
$18 → $6
Mar-09-22 Upgrade Oppenheimer
Perform → Outperform
$21
Nov-08-21 Upgrade The Benchmark Company
Hold → Buy
$20
Sep-10-21 Initiated BofA Securities
Neutral
$18
Jun-28-21 Upgrade Stifel
Hold → Buy
$22 → $24
May-18-21 Resumed Goldman
Neutral
$24
Feb-22-21 Downgrade The Benchmark Company
Buy → Hold
Show Previous Ratings
Sep-03-24 09:00AM
Aug-13-24 12:00PM
Aug-09-24 10:58AM
Aug-08-24 05:55PM
04:49PM
(Associated Press Finance)
04:15PM
Loading…
04:15PM
Aug-01-24 06:00PM
(PR Newswire) -5.22%
-5.51%
Jun-12-24 09:30AM
May-30-24 06:00PM
May-10-24 04:41PM
03:14PM
11:33AM
10:35AM
(Thomson Reuters StreetEvents)
May-09-24 05:39PM
(Associated Press Finance)
04:15PM
06:00PM
Loading…
May-02-24 06:00PM
Apr-03-24 11:30AM
Mar-25-24 10:00AM
Mar-22-24 02:00PM
Mar-06-24 12:33PM
Mar-05-24 10:07AM
09:13AM
09:00AM
07:19AM
(Thomson Reuters StreetEvents)
Mar-04-24 05:30PM
04:51PM
04:42PM
(Associated Press Finance)
04:15PM
08:30AM
Feb-27-24 06:00PM
06:00PM
Loading…
Feb-26-24 06:00PM
Feb-20-24 10:00AM
Jan-03-24 06:00PM
Dec-11-23 06:00PM
Dec-07-23 11:31AM
Nov-09-23 08:39AM
Nov-08-23 11:47AM
Nov-07-23 05:28PM
(Associated Press Finance)
04:15PM
Oct-31-23 06:00PM
Oct-26-23 10:02AM
Oct-23-23 10:08AM
Oct-13-23 08:30AM
Oct-02-23 09:00AM
Sep-27-23 09:00AM
Sep-14-23 07:54AM
Sep-13-23 09:00AM
Sep-07-23 11:31AM
Sep-06-23 06:00PM
Aug-17-23 07:02PM
Aug-09-23 09:25AM
Aug-08-23 05:30PM
04:23PM
04:15PM
11:08AM
(American City Business Journals)
Aug-07-23 10:23AM
06:30AM
Aug-01-23 06:00PM
Jul-24-23 03:48AM
Jul-16-23 08:49AM
Jun-12-23 06:00PM
Jun-08-23 12:55PM
11:31AM
May-10-23 11:28AM
09:16AM
May-09-23 06:45PM
05:41PM
04:15PM
May-08-23 09:29AM
May-04-23 10:00AM
May-02-23 10:01AM
Apr-27-23 08:30AM
Apr-19-23 08:38AM
Apr-17-23 05:00PM
(PR Newswire) +6.26%
-5.67%
Apr-16-23 06:30AM
Apr-13-23 10:59AM
Apr-11-23 08:57AM
Apr-10-23 10:07AM
Apr-02-23 08:27AM
Mar-30-23 11:30AM
Mar-29-23 05:44PM
Mar-24-23 12:00PM
Mar-22-23 09:35AM
Mar-14-23 03:43AM
Feb-28-23 05:15PM
Feb-24-23 10:23AM
07:29AM
Feb-23-23 06:20PM
05:24PM
04:30PM
Jan-09-23 09:04AM
Jan-04-23 09:00AM
Dec-12-22 10:05AM
Dec-05-22 08:00AM
Nov-10-22 09:05AM
07:58AM
Nov-09-22 09:00AM
Nov-04-22 12:35PM
Nov-03-22 06:35PM
Oct-28-22 10:00AM
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zalevsky Jonathan Chief R&D Officer Aug 19 '24 Sale 1.28 6,866 8,788 250,804 Aug 20 09:15 PM Wilson Mark Andrew Chief Legal Officer Aug 19 '24 Sale 1.28 5,651 7,233 225,263 Aug 20 09:15 PM ROBIN HOWARD W President & CEO Aug 19 '24 Sale 1.28 14,881 19,048 848,358 Aug 20 09:14 PM Wilson Mark Andrew Officer Aug 19 '24 Proposed Sale 1.28 5,651 7,211 Aug 19 04:13 PM ROBIN HOWARD W Officer Aug 19 '24 Proposed Sale 1.28 14,881 18,990 Aug 19 04:03 PM Zalevsky Jonathan Officer Aug 19 '24 Proposed Sale 1.28 6,866 8,762 Aug 19 03:45 PM CHESS ROBERT Director Jun 14 '24 Sale 1.20 19,500 23,400 255,273 Jun 14 06:02 PM ROBIN HOWARD W President & CEO May 17 '24 Sale 1.75 16,650 29,138 863,239 May 20 09:14 PM Zalevsky Jonathan Chief R&D Officer May 17 '24 Sale 1.75 7,355 12,871 257,670 May 20 09:13 PM Wilson Mark Andrew Chief Legal Officer May 17 '24 Sale 1.75 6,260 10,955 230,414 May 20 09:12 PM Deep Track Capital, LP 10% Owner May 10 '24 Sale 1.78 56,000 99,630 18,344,000 May 13 04:36 PM Zalevsky Jonathan Chief R&D Officer Feb 20 '24 Sale 0.68 9,014 6,130 265,025 Feb 22 08:19 PM Wilson Mark Andrew Chief Legal Officer Feb 20 '24 Sale 0.68 7,606 5,172 236,674 Feb 22 08:17 PM ROBIN HOWARD W President & CEO Feb 20 '24 Sale 0.68 20,033 13,622 879,889 Feb 22 08:16 PM Zalevsky Jonathan Chief R&D Officer Nov 17 '23 Sale 0.49 9,646 4,727 274,039 Nov 20 09:02 PM Wilson Mark Andrew Chief Legal Officer Nov 17 '23 Sale 0.49 7,179 3,518 243,780 Nov 20 09:00 PM ROBIN HOWARD W President & CEO Nov 17 '23 Sale 0.49 19,877 9,740 899,922 Nov 20 08:58 PM
Index RUT P/E - EPS (ttm) -3.81 Insider Own 4.27% Shs Outstand 57.56M Perf Week -1.09%
Market Cap 2.72B Forward P/E - EPS next Y -2.39 Insider Trans -1.65% Shs Float 56.09M Perf Month 5.23%
Income -220.31M PEG - EPS next Q -0.70 Inst Own 106.35% Short Float 16.73% Perf Quarter -8.89%
Sales 295.21M P/S 9.22 EPS this Y 4.32% Inst Trans 2.41% Short Ratio 9.71 Perf Half Y 28.89%
Book/sh 8.39 P/B 5.53 EPS next Y 30.61% ROA -30.42% Short Interest 9.38M Perf Year 129.90%
Cash/sh 4.94 P/C 9.40 EPS next 5Y - ROE -38.36% 52W Range 14.42 - 60.90 Perf YTD 25.99%
Dividend Est. - P/FCF - EPS past 5Y -6.09% ROI -39.08% 52W High -23.74% Beta 1.76
Dividend TTM - Quick Ratio 4.52 Sales past 5Y 60.13% Gross Margin 40.53% 52W Low 222.05% ATR (14) 2.68
Dividend Ex-Date - Current Ratio 4.91 EPS Y/Y TTM -3.16% Oper. Margin -63.17% RSI (14) 53.94 Volatility 4.83% 5.77%
Employees 919 Debt/Eq 0.18 Sales Y/Y TTM 25.37% Profit Margin -74.63% Recom 1.83 Target Price 51.80
Option/Short Yes / Yes LT Debt/Eq 0.15 EPS Q/Q -46.26% Payout - Rel Volume 1.46 Prev Close 47.99
Sales Surprise 5.25% EPS Surprise -92.43% Sales Q/Q 27.81% Earnings Aug 02 BMO Avg Volume 966.19K Price 46.44
SMA20 7.02% SMA50 -2.42% SMA200 14.48% Trades
Volume 1,409,324 Change -3.23%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-04-24 Initiated Guggenheim
Buy
$53
Jan-17-24 Upgrade Goldman
Neutral → Buy
$25 → $45
Sep-27-23 Initiated Berenberg
Buy
$27
Jan-05-23 Initiated Scotiabank
Sector Outperform
$33
Jan-03-23 Upgrade Evercore ISI
In-line → Outperform
$28 → $36
Mar-02-22 Resumed Cowen
Outperform
Oct-15-21 Resumed Cowen
Outperform
Jun-29-21 Initiated William Blair
Outperform
Jun-04-21 Initiated Goldman
Neutral
$110
Apr-12-21 Initiated Piper Sandler
Overweight
$150
Feb-05-21 Downgrade JP Morgan
Neutral → Underweight
$100
Jan-04-21 Downgrade Evercore ISI
Outperform → In-line
Oct-20-20 Initiated SVB Leerink
Mkt Perform
$90
May-31-19 Initiated Evercore ISI
Outperform
Nov-26-18 Initiated JP Morgan
Neutral
$27
Show Previous Ratings
Sep-12-24 08:00AM
Sep-09-24 08:00AM
Sep-08-24 03:55PM
11:49AM
Aug-27-24 08:00AM
09:45AM
Loading…
Aug-14-24 09:45AM
Aug-08-24 08:00AM
Aug-07-24 06:47AM
Aug-06-24 08:00AM
Aug-05-24 11:20AM
08:00AM
Aug-02-24 08:40AM
07:37AM
(Associated Press Finance)
07:30AM
Jul-30-24 02:17AM
10:00AM
Loading…
Jul-26-24 10:00AM
Jul-18-24 08:00AM
Jul-11-24 08:00AM
Jul-10-24 08:00AM
Jul-09-24 08:00AM
Jul-01-24 07:08PM
02:31PM
Jun-06-24 08:00AM
Jun-04-24 08:00AM
May-24-24 04:58PM
(Investor's Business Daily)
May-23-24 08:00AM
May-22-24 12:00PM
May-13-24 08:00AM
May-10-24 06:00AM
May-08-24 08:00AM
03:55PM
Loading…
May-03-24 03:55PM
01:58PM
01:22PM
10:02AM
06:47AM
(Thomson Reuters StreetEvents)
04:05AM
May-02-24 09:00PM
05:35PM
04:33PM
(Associated Press Finance)
04:05PM
Apr-30-24 03:20PM
Apr-25-24 11:31AM
Apr-18-24 08:00AM
Mar-28-24 08:00AM
Mar-05-24 08:00AM
Feb-22-24 08:00AM
Feb-13-24 01:59PM
Feb-10-24 05:28AM
Feb-07-24 08:00AM
Feb-06-24 08:05AM
08:00AM
Feb-05-24 08:09AM
08:00AM
Feb-02-24 11:42PM
(Thomson Reuters StreetEvents) +10.01%
07:55AM
07:36AM
(Associated Press Finance)
07:30AM
Jan-24-24 08:00AM
Jan-16-24 08:00AM
Jan-08-24 08:00AM
Jan-05-24 08:00AM
Dec-19-23 12:44PM
Dec-18-23 08:00AM
Dec-15-23 08:11AM
Nov-20-23 08:55AM
Nov-18-23 01:29AM
(Thomson Reuters StreetEvents)
Nov-17-23 04:03PM
(Investor's Business Daily) +25.90%
08:40AM
08:28AM
07:47AM
(Associated Press Finance)
07:30AM
Nov-14-23 08:00AM
Nov-13-23 08:00AM
Nov-08-23 08:00AM
Nov-02-23 04:05PM
(Business Wire) +10.82%
+7.80%
Oct-31-23 08:00AM
Oct-16-23 10:43AM
Oct-06-23 12:08PM
11:44AM
Oct-05-23 08:00AM
Oct-03-23 08:00AM
Sep-27-23 08:00AM
Sep-26-23 01:02PM
12:40PM
Sep-20-23 12:11PM
Sep-14-23 12:56PM
12:31PM
Sep-05-23 08:00AM
Aug-31-23 03:10AM
03:00AM
Aug-22-23 08:00AM
Aug-11-23 01:39PM
Aug-07-23 09:53AM
08:00AM
Aug-04-23 01:21PM
08:45AM
07:37AM
07:30AM
Jul-20-23 08:00AM
Jul-18-23 09:50AM
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Green Paula Officer Sep 20 '24 Proposed Sale 46.94 297 13,941 Sep 20 03:29 PM Leproust Emily M. Officer Sep 20 '24 Proposed Sale 46.94 1,730 81,208 Sep 20 03:28 PM Cho Dennis Officer Sep 20 '24 Proposed Sale 46.94 234 10,984 Sep 20 03:08 PM Cho Dennis See Remarks Sep 16 '24 Sale 46.42 94 4,364 78,627 Sep 18 04:05 PM Cho Dennis Officer Sep 16 '24 Proposed Sale 46.42 94 4,364 Sep 16 03:33 PM Cho Dennis See Remarks Sep 06 '24 Sale 39.16 275 10,769 78,721 Sep 10 04:04 PM Green Paula SVP of Human Resources Sep 06 '24 Sale 39.16 912 35,715 88,192 Sep 10 04:03 PM WERNER ROBERT F. Chief Accounting Officer Sep 06 '24 Sale 39.16 240 9,399 38,724 Sep 10 04:03 PM Leproust Emily M. Chief Executive Officer Sep 06 '24 Sale 39.16 2,340 91,637 497,253 Sep 10 04:03 PM WERNER ROBERT F. Officer Sep 06 '24 Proposed Sale 39.16 240 9,399 Sep 06 03:27 PM Green Paula Officer Sep 06 '24 Proposed Sale 39.16 912 35,715 Sep 06 03:26 PM Cho Dennis Officer Sep 06 '24 Proposed Sale 39.16 275 10,769 Sep 06 03:19 PM Leproust Emily M. Officer Sep 06 '24 Proposed Sale 39.16 2,340 91,636 Sep 06 03:16 PM WERNER ROBERT F. Chief Accounting Officer Aug 23 '24 Sale 43.14 813 35,074 38,964 Aug 27 04:05 PM WERNER ROBERT F. Officer Aug 23 '24 Proposed Sale 43.14 813 35,075 Aug 23 03:21 PM Cho Dennis See Remarks Aug 05 '24 Sale 39.93 709 28,308 78,996 Aug 07 04:05 PM Finn Patrick John President and COO Aug 05 '24 Sale 39.93 2,885 115,187 168,327 Aug 07 04:05 PM Leproust Emily M. Chief Executive Officer Aug 05 '24 Sale 39.93 5,139 205,180 499,593 Aug 07 04:05 PM Green Paula SVP of Human Resources Aug 05 '24 Sale 39.93 1,137 45,396 88,837 Aug 07 04:05 PM WERNER ROBERT F. Chief Accounting Officer Aug 05 '24 Sale 39.93 168 6,708 39,777 Aug 07 04:05 PM Banyai William Officer Aug 06 '24 Proposed Sale 45.30 1,176 53,273 Aug 06 10:13 AM WERNER ROBERT F. Officer Aug 05 '24 Proposed Sale 39.93 168 6,708 Aug 05 03:47 PM Cho Dennis Officer Aug 05 '24 Proposed Sale 39.93 709 28,307 Aug 05 03:35 PM Leproust Emily M. Officer Aug 05 '24 Proposed Sale 39.93 5,139 205,179 Aug 05 03:25 PM Green Paula Officer Aug 05 '24 Proposed Sale 39.93 1,137 45,396 Aug 05 03:23 PM Finn Patrick John Officer Aug 05 '24 Proposed Sale 39.93 2,885 115,186 Aug 05 03:14 PM Banyai William Officer Aug 05 '24 Proposed Sale 39.93 1,415 56,495 Aug 05 03:10 PM Banyai William Officer Aug 01 '24 Proposed Sale 55.34 18,777 1,039,119 Aug 01 10:39 AM Finn Patrick John President and COO Jul 23 '24 Sale 56.62 2,207 124,971 171,212 Jul 25 04:05 PM Laponis Adam Chief Financial Officer Jul 09 '24 Sale 48.91 842 41,185 73,602 Jul 11 04:05 PM Cho Dennis See Remarks Jul 02 '24 Sale 48.00 126 6,048 79,705 Jul 05 04:05 PM Leproust Emily M. Chief Executive Officer Jul 02 '24 Sale 48.00 1,114 53,474 504,732 Jul 05 04:05 PM Green Paula SVP of Human Resources Jul 02 '24 Sale 48.00 322 15,457 89,974 Jul 05 04:05 PM Finn Patrick John President and COO Jul 02 '24 Sale 48.00 476 22,849 173,419 Jul 05 04:05 PM Leproust Emily M. Chief Executive Officer Jun 20 '24 Sale 49.41 1,732 85,578 505,846 Jun 24 04:05 PM Green Paula SVP of Human Resources Jun 20 '24 Sale 49.41 297 14,675 90,296 Jun 24 04:05 PM Cho Dennis See Remarks Jun 20 '24 Sale 49.41 234 11,562 79,831 Jun 24 04:05 PM Cho Dennis See Remarks Jun 14 '24 Sale 51.04 95 4,848 80,065 Jun 18 04:05 PM Cho Dennis See Remarks Jun 06 '24 Sale 51.33 276 14,167 80,160 Jun 10 04:05 PM Green Paula SVP of Human Resources Jun 06 '24 Sale 51.33 918 47,120 90,593 Jun 10 04:05 PM WERNER ROBERT F. Chief Accounting Officer Jun 06 '24 Sale 51.33 242 12,422 39,945 Jun 10 04:05 PM Leproust Emily M. Chief Executive Officer Jun 06 '24 Sale 51.33 2,408 123,600 507,578 Jun 10 04:05 PM Banyai William See Remark May 03 '24 Sale 37.13 798 29,633 345,188 May 07 04:05 PM Cho Dennis See Remarks May 03 '24 Sale 37.13 568 21,092 80,436 May 07 04:05 PM Green Paula SVP of Human Resources May 03 '24 Sale 37.13 910 33,792 91,511 May 07 04:05 PM Leproust Emily M. Chief Executive Officer May 03 '24 Sale 37.13 4,163 154,589 509,986 May 07 04:05 PM WERNER ROBERT F. Chief Accounting Officer May 03 '24 Sale 37.13 132 4,902 43,548 May 07 04:05 PM Finn Patrick John President and COO May 03 '24 Sale 37.13 2,311 85,817 173,895 May 07 04:05 PM Finn Patrick John President and COO Apr 23 '24 Sale 30.12 2,174 65,483 176,206 Apr 25 04:05 PM Laponis Adam Chief Financial Officer Apr 09 '24 Sale 33.16 556 18,434 74,444 Apr 11 04:05 PM Finn Patrick John President and COO Apr 02 '24 Sale 32.74 492 16,106 178,380 Apr 04 04:05 PM Banyai William See Remark Apr 02 '24 Sale 32.74 327 10,705 345,986 Apr 04 04:05 PM Leproust Emily M. Chief Executive Officer Apr 02 '24 Sale 32.74 1,132 37,057 514,149 Apr 04 04:05 PM Cho Dennis See Remarks Apr 02 '24 Sale 32.74 129 4,223 81,004 Apr 04 04:05 PM Green Paula SVP of Human Resources Apr 02 '24 Sale 32.74 229 7,497 92,421 Apr 04 04:05 PM Cho Dennis See Remarks Mar 20 '24 Sale 33.52 230 7,709 81,133 Mar 22 04:05 PM Banyai William See Remark Mar 20 '24 Sale 33.52 442 14,814 346,313 Mar 22 04:05 PM Leproust Emily M. Chief Executive Officer Mar 20 '24 Sale 33.52 1,128 37,806 515,281 Mar 22 04:05 PM Green Paula SVP of Human Resources Mar 20 '24 Sale 33.52 200 6,703 92,650 Mar 22 04:05 PM Cho Dennis See Remarks Mar 14 '24 Sale 34.60 93 3,218 81,363 Mar 18 04:05 PM Cho Dennis See Remarks Mar 06 '24 Sale 37.43 272 10,181 81,456 Mar 08 04:05 PM WERNER ROBERT F. Chief Accounting Officer Mar 06 '24 Sale 37.43 181 6,775 43,680 Mar 08 04:05 PM Leproust Emily M. Chief Executive Officer Mar 06 '24 Sale 37.43 1,487 55,658 516,409 Mar 08 04:05 PM Green Paula SVP of Human Resources Mar 06 '24 Sale 37.43 600 22,458 92,850 Mar 08 04:05 PM Banyai William See Remark Mar 06 '24 Sale 37.43 549 20,549 346,755 Mar 08 04:05 PM CHESS ROBERT Director Feb 08 '24 Sale 34.98 4,110 143,784 64,169 Feb 09 04:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
